Literature DB >> 16804438

Immune reconstitution syndrome from nontuberculous mycobacterial infection after initiation of antiretroviral therapy in children with HIV infection.

Thanyawee Puthanakit1, Peninnah Oberdorfer, Nuthapong Ukarapol, Noppadon Akarathum, Suchart Punjaisee, Thira Sirisanthana, Virat Sirisanthana.   

Abstract

The immune reconstitution syndrome caused by nontuberculous mycobacterial (NTM) infection is reported in 9 of 153 HIV-infected children 2 to 26 weeks after initiation of antiretroviral therapy. The clinical syndrome included fever and dyspnea (2 children), fever and abdominal pain (3), subcutaneous nodules or suppurative lymphadenitis (4). The causative species were Mycobacterium avium (4), Mycobacterium scrofulaceum (3), Mycobacterium kansasii (1) and Mycobacterium simiae (1).

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16804438      PMCID： PMC1924531          DOI： 10.1097/01.inf.0000225786.00940.37

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


  20 in total

Review 1.  Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy.

Authors:  Samuel A Shelburne; Richard J Hamill; Maria C Rodriguez-Barradas; Stephen B Greenberg; Robert L Atmar; Daniel W Musher; Joseph C Gathe; Fehmida Visnegarwala; Barbara W Trautner
Journal:  Medicine (Baltimore)       Date:  2002-05       Impact factor: 1.889

2.  Mycobacterial lymphadenitis associated with the initiation of combination antiretroviral therapy.

Authors:  P Phillips; M B Kwiatkowski; M Copland; K Craib; J Montaner
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1999-02-01

3.  Mycobacterium avium complex in HIV-infected Thai children.

Authors:  Wanatpreeya Phongsamart; Kulkanya Chokephaibulkit; Angkana Chaiprasert; Nirun Vanprapa; Sanay Chearskul; Rangsima Lolekha
Journal:  J Med Assoc Thai       Date:  2002-08

4.  Treating opportunistic infections among HIV-exposed and infected children: recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America.

Authors:  Lynne M Mofenson; James Oleske; Leslie Serchuck; Russell Van Dyke; Cathy Wilfert
Journal:  Clin Infect Dis       Date:  2005-02-01       Impact factor: 9.079

5.  Prevalence of disseminated Mycobacterium avium complex infection in Thai AIDS patients.

Authors:  C Chuchottaworn; B Sathapatayawongs; S Tansuphsawadikul; S Suwanagool; P Kantipong; S Pornchaipoonthavee
Journal:  J Med Assoc Thai       Date:  1999-07

6.  CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.

Authors:  Gilbert R Kaufmann; Luc Perrin; Guiseppe Pantaleo; Milos Opravil; Hansjakob Furrer; Amalio Telenti; Bernard Hirschel; Bruno Ledergerber; Pietro Vernazza; Enos Bernasconi; Martin Rickenbach; Matthias Egger; Manuel Battegay
Journal:  Arch Intern Med       Date:  2003-10-13

7.  Differentiation between Mycobacterium tuberculosis and Mycobacterium avium by amplification of the 16S-23S ribosomal DNA spacer.

Authors:  A Sansila; P Hongmanee; C Chuchottaworn; S Rienthong; D Rienthong; P Palittapongarnpim
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

8.  Immune reconstitution in HIV-infected patients.

Authors:  Hans H Hirsch; Gilbert Kaufmann; Pedram Sendi; Manuel Battegay
Journal:  Clin Infect Dis       Date:  2004-04-05       Impact factor: 9.079

9.  Paradoxical reactions in HIV and pulmonary TB.

Authors:  J W Chien; J L Johnson
Journal:  Chest       Date:  1998-09       Impact factor: 9.410

10.  Adult respiratory distress syndrome as a severe immune reconstitution disease following the commencement of highly active antiretroviral therapy.

Authors:  N R Goldsack; S Allen; M C I Lipman
Journal:  Sex Transm Infect       Date:  2003-08       Impact factor: 3.519
View more
  9 in total

1.  Pediatric HIV immune reconstitution inflammatory syndrome.

Authors:  David R Boulware; Steven Callens; Savita Pahwa
Journal:  Curr Opin HIV AIDS       Date:  2008-07       Impact factor: 4.283

2.  Executive summary: 2013 update of the guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman
Journal:  Pediatr Infect Dis J       Date:  2013-12       Impact factor: 2.129

3.  Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

4.  Reduced rate of adverse reactions to the BCG vaccine in children exposed to the vertical transmission of HIV infection and in HIV-infected children from an endemic setting in Brazil.

Authors:  Regina Célia de Souza Campos Fernandes; Luciana Cordeiro de Araújo; Enrique Medina-Acosta
Journal:  Eur J Pediatr       Date:  2008-09-03       Impact factor: 3.183

5.  Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  Lynne M Mofenson; Michael T Brady; Susie P Danner; Kenneth L Dominguez; Rohan Hazra; Edward Handelsman; Peter Havens; Steve Nesheim; Jennifer S Read; Leslie Serchuck; Russell Van Dyke
Journal:  MMWR Recomm Rep       Date:  2009-09-04

6.  Incidence of opportunistic illness before and after initiation of highly active antiretroviral therapy in children.

Authors:  Steven R Nesheim; Felicia Hardnett; John T Wheeling; George K Siberry; Mary E Paul; Patricia Emmanuel; Beverly Bohannon; Kenneth Dominguez
Journal:  Pediatr Infect Dis J       Date:  2013-10       Impact factor: 2.129

Review 7.  Mycobacterium simiae complex infection in an immunocompetent child.

Authors:  Andrea T Cruz; Veronica K Goytia; Jeffrey R Starke
Journal:  J Clin Microbiol       Date:  2007-05-30       Impact factor: 5.948

8.  Characterization of Proinflammatory Responses and Innate Signaling Activation in Macrophages Infected with Mycobacterium scrofulaceum.

Authors:  Ki-Hye Kim; Tae-Sung Kim; Joy G Lee; Jeong-Kyu Park; Miso Yang; Jin-Man Kim; Eun-Kyeong Jo; Jae-Min Yuk
Journal:  Immune Netw       Date:  2014-12-22       Impact factor: 6.303

9.  Urgent versus post-stabilisation antiretroviral treatment in hospitalised HIV-infected children in Kenya (PUSH): a randomised controlled trial.

Authors:  Irene N Njuguna; Lisa M Cranmer; Vincent O Otieno; Cyrus Mugo; Hellen M Okinyi; Sarah Benki-Nugent; Barbra Richardson; Joshua Stern; Elizabeth Maleche-Obimbo; Dalton C Wamalwa; Grace C John-Stewart
Journal:  Lancet HIV       Date:  2017-11-14       Impact factor: 12.767
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.